http://www.rxpgnews.com/ Medical News and Information Thu, 21 Aug 2008 02:00:28 PST en-us http://www.rxpgnews.com/smallcellcarcinomalung/Survival_Not_Improved_With_Dose-Dense_Chemotherapy_1353_1353.shtml Small Cell Carcinoma A randomized trial has found that a dose-dense regimen of chemotherapy with blood progenitor cell support did not improve survival compared with standard-dose chemotherapy in patients with small-cell lung cancer (SCLC). However, patients who received the dose-dense regimen had fewer infections and fewer days of treatment than patients who received standard chemotherapy. Wed, 04 May 2005 17:26:00 PST http://www.rxpgnews.com/smallcellcarcinomalung/Survival_Not_Improved_With_Dose-Dense_Chemotherapy_1353_1353.shtml